Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction
Clinical trial NCT06017609 · COMPLETED
Trial details
- NCT number
- NCT06017609
- Sponsor
- Akros Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-20
- Primary completion
- 2026-05-18
- Enrollment
- 314
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.